[{"Assets_0_Q1_USD":155372000.0,"CommonStockSharesOutstanding_0_Q1_shares":98702000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-19653000.0,"NetIncomeLoss_1_Q1_USD":-25777000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":98592000.0,"StockholdersEquity_0_Q1_USD":62054000.0,"Ticker":"BCRX","CIK":"882796","name":"BIOCRYST PHARMACEUTICALS INC","OfficialName":"BioCryst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1887243586.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]